vs
Fulgent Genetics, Inc.（FLGT）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是Fulgent Genetics, Inc.的2.1倍（$151.1M vs $71.1M），STURM RUGER & CO INC同比增速更快（3.6% vs -3.2%），过去两年STURM RUGER & CO INC的营收复合增速更高（5.1% vs 0.1%）
Fulgent Genetics是一家分子诊断技术企业，开发并提供覆盖携带者筛查、肿瘤基因检测、传染病检测、遗传性疾病分析的多元基因检测服务，主要客户为北美地区的医疗机构、药企、科研院所及公共卫生组织。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
FLGT vs RGR — 直观对比
营收规模更大
RGR
是对方的2.1倍
$71.1M
营收增速更快
RGR
高出6.8%
-3.2%
两年增速更快
RGR
近两年复合增速
0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.1M | $151.1M |
| 净利润 | — | — |
| 毛利率 | 30.2% | 17.8% |
| 营业利润率 | 21.1% | 2.3% |
| 净利率 | — | — |
| 营收同比 | -3.2% | 3.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.04 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLGTRGR
| Q1 26 | $71.1M | — | ||
| Q4 25 | $83.3M | $151.1M | ||
| Q3 25 | $84.1M | $126.8M | ||
| Q2 25 | $81.8M | $132.5M | ||
| Q1 25 | $73.5M | $135.7M | ||
| Q4 24 | $76.2M | $145.8M | ||
| Q3 24 | $71.7M | $122.3M | ||
| Q2 24 | $71.0M | $130.8M |
净利润FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | $-23.4M | — | ||
| Q3 25 | $-6.6M | $1.6M | ||
| Q2 25 | $-19.0M | $-17.2M | ||
| Q1 25 | $-11.5M | $7.8M | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $-14.6M | $4.7M | ||
| Q2 24 | $-8.7M | $8.3M |
毛利率FLGTRGR
| Q1 26 | 30.2% | — | ||
| Q4 25 | 39.1% | 17.8% | ||
| Q3 25 | 42.2% | 15.1% | ||
| Q2 25 | 42.1% | 3.9% | ||
| Q1 25 | 38.6% | 22.0% | ||
| Q4 24 | 41.8% | 22.8% | ||
| Q3 24 | 37.3% | 18.5% | ||
| Q2 24 | 37.3% | 22.3% |
营业利润率FLGTRGR
| Q1 26 | 21.1% | — | ||
| Q4 25 | -43.5% | 2.3% | ||
| Q3 25 | -18.3% | -2.7% | ||
| Q2 25 | -24.1% | -15.6% | ||
| Q1 25 | -26.9% | 6.2% | ||
| Q4 24 | -21.2% | 7.8% | ||
| Q3 24 | -23.8% | 3.1% | ||
| Q2 24 | -26.6% | 6.9% |
净利率FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | -28.1% | — | ||
| Q3 25 | -7.9% | 1.2% | ||
| Q2 25 | -23.2% | -13.0% | ||
| Q1 25 | -15.7% | 5.7% | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | -20.4% | 3.9% | ||
| Q2 24 | -12.3% | 6.3% |
每股收益（稀释后）FLGTRGR
| Q1 26 | $0.04 | — | ||
| Q4 25 | — | $0.22 | ||
| Q3 25 | — | $0.10 | ||
| Q2 25 | — | $-1.05 | ||
| Q1 25 | — | $0.46 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.4M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $283.8M |
| 总资产 | $1.2B | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FLGTRGR
| Q1 26 | $23.4M | — | ||
| Q4 25 | $50.2M | $92.5M | ||
| Q3 25 | $117.6M | $80.8M | ||
| Q2 25 | $87.9M | $101.4M | ||
| Q1 25 | $67.3M | $108.3M | ||
| Q4 24 | $55.1M | $105.5M | ||
| Q3 24 | $58.0M | $96.0M | ||
| Q2 24 | $65.1M | $105.6M |
股东权益FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $283.8M | ||
| Q3 25 | $1.1B | $279.6M | ||
| Q2 25 | $1.1B | $289.3M | ||
| Q1 25 | $1.1B | $321.5M | ||
| Q4 24 | $1.1B | $319.6M | ||
| Q3 24 | $1.1B | $314.9M | ||
| Q2 24 | $1.1B | $321.5M |
总资产FLGTRGR
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $342.0M | ||
| Q3 25 | $1.2B | $342.3M | ||
| Q2 25 | $1.2B | $349.5M | ||
| Q1 25 | $1.2B | $379.0M | ||
| Q4 24 | $1.2B | $384.0M | ||
| Q3 24 | $1.2B | $373.5M | ||
| Q2 24 | $1.2B | $376.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.5M |
| 自由现金流经营现金流 - 资本支出 | — | $12.3M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $38.5M |
8季度趋势，按日历期对齐
经营现金流FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | $-78.1M | $15.5M | ||
| Q3 25 | $11.1M | $12.9M | ||
| Q2 25 | $-30.2M | $14.7M | ||
| Q1 25 | $-4.4M | $11.1M | ||
| Q4 24 | $25.0M | $20.0M | ||
| Q3 24 | $-15.5M | $9.4M | ||
| Q2 24 | $4.3M | $18.7M |
自由现金流FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | $-83.1M | $12.3M | ||
| Q3 25 | $5.1M | $7.0M | ||
| Q2 25 | $-37.0M | $9.1M | ||
| Q1 25 | $-9.1M | $10.0M | ||
| Q4 24 | $21.2M | $16.4M | ||
| Q3 24 | $-35.0M | $2.6M | ||
| Q2 24 | $-8.7M | $10.1M |
自由现金流率FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | -99.7% | 8.2% | ||
| Q3 25 | 6.0% | 5.5% | ||
| Q2 25 | -45.2% | 6.9% | ||
| Q1 25 | -12.5% | 7.4% | ||
| Q4 24 | 27.9% | 11.2% | ||
| Q3 24 | -48.8% | 2.1% | ||
| Q2 24 | -12.2% | 7.7% |
资本支出强度FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 2.1% | ||
| Q3 25 | 7.2% | 4.6% | ||
| Q2 25 | 8.3% | 4.2% | ||
| Q1 25 | 6.4% | 0.8% | ||
| Q4 24 | 5.0% | 2.5% | ||
| Q3 24 | 27.2% | 5.5% | ||
| Q2 24 | 18.2% | 6.6% |
现金转化率FLGTRGR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLGT
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
